
Leiter discusses the growth of incretin-based therapies through all aspects of the cardio-kidney-metabolic syndrome space.

Larence Leiter, MD, is the director of the Lipid Clinic and associate director of the Clinical Nutrition and Risk Factor Modification centre at St. Michael’s Hospital in Toronto.

Leiter discusses the growth of incretin-based therapies through all aspects of the cardio-kidney-metabolic syndrome space.

Leiter discusses the importance of earlier and more dramatic lipid-lowering interventions in patients with diabetes at risk of cardiovascular disease.